Literature DB >> 31612404

Signal Alteration of Substantia Nigra on 3.0T Susceptibility-weighted Imaging in Parkinson's Disease and Vascular Parkinsonism.

Xue-Jun Zhao1, Xi-Yuan Niu2, He-Yang You2, Min Zhou1, Xue-Bing Ji3, Ying Liu3, Lei Wu4, Xiao-Ling Ding5.   

Abstract

Recent researches have found that 7 Tesla SWI can detect the alteration of substantia nigra hyperintensity in Parkinson's disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP). The aim of this study was to investigate whether 3 Tesla SWI (3T SWI) can visualize anatomical alterations occurring in a hyperintense structure of the substantia nigra in PD and vascular parkinsonism (VP), and whether the evaluation of abnormal signal can be used as a factor in the differential diagnosis of PD and VP. Using 3 Tesla MRI, we evaluated 38 healthy subjects, 33 patients with PD and 34 patients with VP. Two blinded readers independently assessed the images. We found that the dorsolateral nigral hyperintensity was absent in 31 of 33 patients with PD and 15 of 34 patients with VP. The dorsolateral nigral hyperintensity was present in 19 of 34 patients with VP and 35 of 38 healthy controls. Group comparisons of absence of dorsolateral nigral hyperintensity revealed significant differences between the patients with PD and those with VP (P<0.001). The sensitivity of SWI for PD was 93.9% and the specificity was 92.1%. Visual assessment of dorsolateral nigral hyperintensity on high-field SWI scans may serve as a new simple diagnostic imaging marker for PD. And our study results indicate that 3T SWI can be used as a tool to identify PD and VP.

Entities:  

Keywords:  Parkinson’s disease; magnetic resonance imaging; substantia nigra; susceptibility-weighted imaging; vascular parkinsonism

Mesh:

Substances:

Year:  2019        PMID: 31612404     DOI: 10.1007/s11596-019-2113-4

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  23 in total

1.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

Authors:  P Damier; E C Hirsch; Y Agid; A M Graybiel
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

2.  Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.

Authors:  Patrice Péran; Andrea Cherubini; Francesca Assogna; Fabrizio Piras; Carlo Quattrocchi; Antonella Peppe; Pierre Celsis; Olivier Rascol; Jean-François Démonet; Alessandro Stefani; Mariangela Pierantozzi; Francesco Ernesto Pontieri; Carlo Caltagirone; Gianfranco Spalletta; Umberto Sabatini
Journal:  Brain       Date:  2010-08-23       Impact factor: 13.501

Review 3.  MDS clinical diagnostic criteria for Parkinson's disease.

Authors:  Ronald B Postuma; Daniela Berg; Matthew Stern; Werner Poewe; C Warren Olanow; Wolfgang Oertel; José Obeso; Kenneth Marek; Irene Litvan; Anthony E Lang; Glenda Halliday; Christopher G Goetz; Thomas Gasser; Bruno Dubois; Piu Chan; Bastiaan R Bloem; Charles H Adler; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

Review 4.  Potential role of high-field MRI for studies in Parkinson's disease.

Authors:  Norbert Schuff
Journal:  Mov Disord       Date:  2009       Impact factor: 10.338

Review 5.  Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.

Authors:  Adriane Gröger; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2012-08-09       Impact factor: 3.575

Review 6.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

7.  MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease.

Authors:  Mirco Cosottini; Daniela Frosini; Ilaria Pesaresi; Mauro Costagli; Laura Biagi; Roberto Ceravolo; Ubaldo Bonuccelli; Michela Tosetti
Journal:  Radiology       Date:  2014-02-26       Impact factor: 11.105

8.  Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.

Authors:  M Cosottini; D Frosini; I Pesaresi; G Donatelli; P Cecchi; M Costagli; L Biagi; R Ceravolo; U Bonuccelli; M Tosetti
Journal:  AJNR Am J Neuroradiol       Date:  2014-11-06       Impact factor: 3.825

9.  New MR sequences in daily practice: susceptibility weighted imaging. A pictorial essay.

Authors:  Roberto Gasparotti; Lorenzo Pinelli; Roberto Liserre
Journal:  Insights Imaging       Date:  2011-03-26

10.  Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.

Authors:  Anna I Blazejewska; Stefan T Schwarz; Alain Pitiot; Mary C Stephenson; James Lowe; Nin Bajaj; Richard W Bowtell; Dorothee P Auer; Penny A Gowland
Journal:  Neurology       Date:  2013-07-10       Impact factor: 9.910

View more
  2 in total

1.  Diagnostic performance of loss of nigral hyperintensity on susceptibility-weighted imaging in parkinsonism: an updated meta-analysis.

Authors:  Pyeong Hwa Kim; Da Hyun Lee; Chong Hyun Suh; Minjae Kim; Woo Hyun Shim; Sang Joon Kim
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

Review 2.  Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson's Disease and Other Movement Disorders: A Meta-Analysis.

Authors:  Yan-Liang Mei; Jing Yang; Zheng-Rong Wu; Ying Yang; Yu-Ming Xu
Journal:  Parkinsons Dis       Date:  2021-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.